Vera Therapeutics Announces 96-week eGFR Stabilization in ORIGIN Phase 2b Study of Atacicept in IgAN in a Late-Breaking Oral Presentation at the American Society of Nephrology Kidney Week 2024 by Seini Moimoi | Oct 26, 2024 | Portfolio News
Alpha-9 Oncology Inc. Announces $175 Million Oversubscribed Series C Financing to Advance Robust Clinical Pipeline of Radiopharmaceuticals by Seini Moimoi | Oct 23, 2024 | Portfolio News
Poseida Therapeutics Announces Nomination of New CAR-T Development Candidate Under Collaboration with Roche by Seini Moimoi | Oct 17, 2024 | Portfolio News
New Clinical Evidence Links Ceribell Point-of-Care EEG to Shorter Hospital Stays and Better Functional Outcomes Compared to Conventional EEG by Seini Moimoi | Oct 16, 2024 | Portfolio News
CeriBell, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares by Seini Moimoi | Oct 15, 2024 | Portfolio News
